Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026)

Savara (SVRA) reported Change in Acquisitions & Divestments of $13.1 million for Q1 2026, down 70.42% year-over-year from $44.4 million in Q1 2025, and down 55.33% quarter-over-quarter from $29.4 million in Q4 2025.

Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Savara (SVRA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $13.1 million in Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $13.1 million, down 70.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $150.9 million (down 10.11% YoY), and the FY2025 annual result was $182.2 million, up 10.42% from the prior year.
  • Change in Acquisitions & Divestments declined to $13.1 million in Q1 2026 per SVRA's latest filing, from $29.4 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $72.3 million in Q2 2022 and troughed at -$72.3 million in Q3 2022.
  • A 5-year average of $31.8 million and a median of $39.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 333.04% in 2022 and fell as far as 309.07% in 2022.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at -$72.3 million in 2022, then surged by 162.78% to $45.4 million in 2023, then grew by 10.02% to $49.9 million in 2024, then plunged by 41.14% to $29.4 million in 2025, then slumped by 55.33% to $13.1 million in 2026.
  • Business Quant data shows SVRA's Change in Acquisitions & Divestments at $13.1 million in Q1 2026, $29.4 million in Q4 2025, and $44.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Savara 1.39 Bn 1.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 13.13 Mn
Mar 31, 2026 13.13 Mn
Dec 31, 2025 29.40 Mn
Dec 31, 2025 29.40 Mn
Sep 30, 2025 44.40 Mn
Sep 30, 2025 44.40 Mn
Jun 30, 2025 64.00 Mn
Jun 30, 2025 64.00 Mn
Mar 31, 2025 44.40 Mn
Mar 31, 2025 44.40 Mn
Dec 31, 2024 49.95 Mn
Dec 31, 2024 49.95 Mn
Sep 30, 2024 40.55 Mn
Sep 30, 2024 40.55 Mn
Jun 30, 2024 33.00 Mn
Jun 30, 2024 33.00 Mn
Mar 31, 2024 41.50 Mn
Mar 31, 2024 41.50 Mn
Dec 31, 2023 45.40 Mn
Dec 31, 2023 45.40 Mn